[New 2004 guidelines of the Breast Organ Committee of AGO].
D000903:Antibiotics, Antineoplastic / Q000009:adverse effects / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000451:nursing*; D002986:Clinical Trials as Topic; D004317:Doxorubicin / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D009362:Neoplasm Metastasis; D010166:Palliative Care; D017410:Practice Guidelines as Topic; D015996:Survival Rate
D000903:Antibiotics, Antineoplastic; D004317:Doxorubicin